According to the latest report by IMARC Group, titled "Infant Phototherapy Devices Market Report by Light Source (Fluorescent Lamps (FL), Light-Emitting Diodes (LEDs), Quartz Halogen Lamps, Gas Discharge Tubes), Configuration (Mobile Device, Fixed Device), End User (Hospital, Neonatal Clinics), and Region 2025-2033," the global infant phototherapy devices market reached a value of USD 92.6 Million in 2024. Infant phototherapy devices are widely used in the treatment of jaundice in the neonatal period. They emit a visible source of light that assist healthcare professionals in removing the bilirubin from an infant’s blood by converting unconjugated bilirubin molecules into water-soluble isomers. They are mainly equipped with halogen spotlights that consist of a blue-green light source since it penetrates the skin easily and is absorbed by bilirubin particles that create a photochemical effect that is helpful in the treatment of jaundice. The demand for infant phototherapy devices is increasing due to their numerous benefits, including enhanced convenience and cost-effective nature.
Global Infant Phototherapy Devices Market Trends:
The global market is primarily driven by the widespread prevalence of neonatal jaundice. Coupled with the growing awareness regarding the treatments available for jaundice among parents, this is creating a positive market outlook. Along with this, the rising investments by private and public agencies in upgrading the overall healthcare infrastructure are providing a boost to the market growth. Moreover, continual technological advancements, such as the introduction of multi-directional illumination phototherapy devices that are designed to uniformly distribute the light source to conduct a more effective jaundice treatment, are gaining prominence across the globe. Other factors, including the increasing birth rate, continuous product innovations, continual improvements in the healthcare infrastructure, the growing initiatives by the government of several countries to provide effective medical services to rural and geographical extended locations, and extensive research and development (R&D) activities conducted by key players, are also influencing the growth of the market. On account of the aforementioned factors, the market is anticipated to reach a value of USD 126.3 Million by 2033, exhibiting a CAGR of 3.34% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Light Source, Configuration, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Atom Medical Corporation, AVI Healthcare Private Limited, Equalize Health, General Electric Company, Ibis Medical Equipment and Systems Pvt Ltd, Natus Medical Incorporated, Ningbo David Medical Device Company Limited, NOVOS Medical Systems, Weyer GmbH and Zhengzhou Dison Instrument and Meter Co. Ltd. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800